Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 20
PROCESS
VALIDATION
For Large Volume Parenteral (LVP)
What is Process Validation Pharmaceutical process validation is the documented verification that a manufacturing process consistently produces products meeting predetermined quality specifications. It Process validation is defined as the Collection and evaluation of data from the process design stage through commercial production, which established scientific evidences that a process is capable of consistently delivering quality product. Phases of Process Validation
Stage 1 Stage 2 Stage 3
Process Design Process Qualification Continued Process Verification Stage 01 Process Design (Stage 1): ● Manufacturing process is planned and designed ● Quality by Design (QbD) principles ● Defined the critical quality attributes (CQAs) like physical, chemical, biological, or microbiological characteristics. (Temperature, pH level, mixing speed, filtration pressure, fill volume) ● After CQAs, Critical process parameters are (CPPs) are defined. ● (Sterility, Potency, Purity, PH, Particulate Matter, Stability) Process Design (Stage 1): ● Critical process parameters can impact the critical quality attributes ● After the CPP have been identified, the manufacturing process is designed. ● Process design also established the control parameters ● Control parameters include monitoring and testing critical process parameters to verify the product quality. ● Risk assessments and critical quality attributes (CQAs). Stage 02 Process Qualification (Stage 2): ● Manufacturing process is validated through series of qualifications ● Installation Qualification ( for equipment’s which are related to process ) ● Operational Qualification :Manufacturing process is tested to ensure it consistently produces the drug product within the defined specifications. ● The final stage of process qualification is performance qualification (PQ) manufacturing process is tested under actual production conditions. Stage 03 Continued Process Verification (Stage 3): ● Process is continuously monitored. ● Routine monitoring of process performance and product quality. ● If any issue detected, corrective actions are taken. ● Process should revalidated. ● It is critical in ensuring that the manufacturing process remains consistent and reliable over time. ● It helps to ensure that the drug product remains safe and effective. Pre- Requisites of Process Validation ● All equipment’s to be used should have been qualified ( IQ,OQ, PQ ) ● The product facility and area should be validated. ● Analytical testing methods to be used should have been fully validated. ● Critical support systems (Water, Compressed air) should be validated. ● Raw and packing materials are in approved stage. ● Staff taking part in the validation work should have been appropriately trained. Types of Process Validation 01 Prospective Validation 03 Retrospective Validation
02 Concurrent Validation 04 Re- Validation
Prospective Validation ● It is establishing documented evidence prior to process implementation that a system does what it proposed to do based on the pre-planned protocol. Under the objective to prove that the process will work in accordance with a validation protocol. ● An experimental plan called validation protocol is executed before the process is put into commercial use. ● It is normally undertaken for a new drug product or new facilities are introduced into a routine pharmaceutical production. Prospective Validation
● Carried out during the development stages by means of a risk
analysis of the production process, which is broken down into individual steps. ● Representing Production, QA, QC, and Engineering person should involve the validation execution Prospective Validation Protocol Consist of :
• Objective, Scope, Responsibilities
• Process flow • A description of the process • A description of the experiment • Details of the equipment’s which is used • The Variables to monitor • Sampling plan • Acceptance limits, Details of methods for recording and evaluating results, including statical analysis. • Summary / Conclusion Concurrent Validation ● Concurrent validation is used to establish documented evidence that a facility and process will perform as they are intended, based on information generated during actual use of the process.
● Validation process is divided into two type depending upon the
testing : In process monitoring and End process testing
● Documented process done as per the prospective validation
protocol. Retrospective Validation ● It is an establishing documented evidence that a process does what it is supposed to do based on review and analysis of historic data. ● As per the Audit observation point or market complaint this type of process validation is performed. ● During Retrospective validation historical data to provide the necessary documentary evidence that the process is doing what it is supposed to do. ● Protocol also contended with the simple steps major step is data analysis and reviewing then the conclusion and recommendations will give based on the trend data. Re- Validation ● Re- Validation provides the evidence that changes in a process and process environments introduced either intentionally or unintentionally, do not adversely affect process characteristics and product quality
● Divided into two categories based on purpose,
○ Re- validation in case of known change ○ Periodic Re- Validation carried out at scheduled intervals. ● Changes of raw materials ( Physical properties such as density, viscosity, particle size) Changes that are likely to ● Change of Starting material require Re- ● Change of Packing material Validation ● Changes of the process parameters ( Mixing Time, Drying temperature)